US Patent Issued to Contineum Therapeutics on March 3 for "Muscarinic acetylcholine M 1 receptor antagonists" (California Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,501, issued on March 3, was assigned to Contineum Therapeutics Inc. (San Diego).

"Muscarinic acetylcholine M 1 receptor antagonists" was invented by Jill Melissa Baccei (San Diego), Yalda Bravo (San Diego), Austin Chih-Yu Chen (San Diego), Jeffrey Roppe (Temecula, Calif.), Thomas Schrader (San Diego) and Yifeng Xiong (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein, inter alia, are compounds which are useful as antagonists of the muscarinic acetylcholine receptor M1 (mAChR M1); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatri...